DK0613687T3 - Anvendelse af pregnanderivat til behandling af tumorer - Google Patents

Anvendelse af pregnanderivat til behandling af tumorer

Info

Publication number
DK0613687T3
DK0613687T3 DK94200523T DK94200523T DK0613687T3 DK 0613687 T3 DK0613687 T3 DK 0613687T3 DK 94200523 T DK94200523 T DK 94200523T DK 94200523 T DK94200523 T DK 94200523T DK 0613687 T3 DK0613687 T3 DK 0613687T3
Authority
DK
Denmark
Prior art keywords
tumors
treatment
derivative
pregnancy
alpha
Prior art date
Application number
DK94200523T
Other languages
Danish (da)
English (en)
Inventor
Godefridus Hermanus Jo Deckers
Helenius Jan Kloosterboer
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0613687T3 publication Critical patent/DK0613687T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fats And Perfumes (AREA)
DK94200523T 1993-03-05 1994-03-02 Anvendelse af pregnanderivat til behandling af tumorer DK0613687T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93200631 1993-03-05

Publications (1)

Publication Number Publication Date
DK0613687T3 true DK0613687T3 (da) 1999-12-06

Family

ID=8213673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94200523T DK0613687T3 (da) 1993-03-05 1994-03-02 Anvendelse af pregnanderivat til behandling af tumorer

Country Status (14)

Country Link
US (1) US5512556A (no)
EP (1) EP0613687B1 (no)
JP (1) JP3391539B2 (no)
KR (1) KR100312061B1 (no)
AT (1) ATE180669T1 (no)
AU (1) AU671706B2 (no)
CA (1) CA2116829C (no)
DE (1) DE69418744T2 (no)
DK (1) DK0613687T3 (no)
ES (1) ES2134313T3 (no)
GR (1) GR3031114T3 (no)
NO (1) NO307447B1 (no)
NZ (1) NZ260017A (no)
ZA (1) ZA941464B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509019B1 (pt) * 1994-09-22 2009-01-13 comprimido isento de solventes orgÂnicos.
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
JP2002527525A (ja) * 1998-10-16 2002-08-27 アクゾ・ノベル・エヌ・ベー （７α，１７α）−１７−ヒドロキシ−７−メチル−１９−ノル−１７−プレグヌ−５（１０）−エン−２０−イン−３−オンを含む高純度組成物
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
BR0013769A (pt) * 1999-09-06 2002-04-30 Akzo Nobel Nv Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide
EP1307471B1 (en) 2000-07-28 2005-05-04 Akzo Nobel N.V. 16alpha-methyl or ethyl substituted estrogens
WO2003032924A2 (en) * 2001-10-18 2003-04-24 Ivax Corporation Novel tibolone formulations
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
KR20040073572A (ko) * 2002-01-22 2004-08-19 악조 노벨 엔.브이. 내인성 에스트로겐의 합성을 예방하는 약물의 투여와관련된 호소 증상의 치료에서의 티볼론
KR20050085024A (ko) * 2002-11-20 2005-08-29 악조 노벨 엔.브이. 티볼론 및 코팅을 포함하는 약학적 정제
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US20060211667A1 (en) * 2005-03-21 2006-09-21 Eric Marchewitz Use of pregnane steroid derivatives for enhancing physical performance
CN116987680A (zh) * 2022-04-25 2023-11-03 复旦大学 支链氨基酸转氨酶1的功能获得性突变体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
FR2706454B1 (fr) * 1993-06-17 1995-09-15 Roussel Uclaf Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
NO940777L (no) 1994-09-06
ZA941464B (en) 1994-09-27
EP0613687A1 (en) 1994-09-07
EP0613687B1 (en) 1999-06-02
US5512556A (en) 1996-04-30
JP3391539B2 (ja) 2003-03-31
ATE180669T1 (de) 1999-06-15
CA2116829C (en) 2004-09-14
DE69418744D1 (de) 1999-07-08
NO307447B1 (no) 2000-04-10
KR100312061B1 (ko) 2001-12-28
NZ260017A (en) 1997-06-24
AU5754294A (en) 1994-09-08
CA2116829A1 (en) 1994-09-06
ES2134313T3 (es) 1999-10-01
NO940777D0 (no) 1994-03-04
AU671706B2 (en) 1996-09-05
DE69418744T2 (de) 1999-11-11
GR3031114T3 (en) 1999-12-31
JPH072673A (ja) 1995-01-06
KR940021064A (ko) 1994-10-17

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
PL350775A1 (en) Pharmaceutical compounds
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
DK0694545T3 (da) Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
TW223016B (no)
GB9302046D0 (en) Antiumoral compound-v
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
DE69528984T2 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
FI941850A0 (fi) Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö
TH15815A (th) การใช้อนุพันธ์เพรคเนม